1984
ORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1
BERKOWITZ G, KELSEY J, LIVOLSI V, HOLFORD T, MERINO M, ORT S, O'CONNOR T, GOLDENBERG I, WHITE C. ORAL CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PRE- AND POSTMENOPAUSAL WOMEN1. American Journal Of Epidemiology 1984, 120: 87-96. PMID: 6741927, DOI: 10.1093/oxfordjournals.aje.a113878.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseOral contraceptive useBreast diseaseOral contraceptivesContraceptive useHospital-based case-control studyOral contraceptive exposureGeneral surgical serviceCase-control studyLong-term useContraceptive exposurePostmenopausal women1Postmenopausal womenPremenopausal womenCystic diseaseStudy groupSurgical servicesDecreased frequencyPast usersDiseaseIncreased occurrenceWomenContraceptivesNegative associationAssociation
1983
Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23
Pastides H, Kelsey J, LiVolsi V, Holford T, Fischer D, Goldenberg I. Oral Contraceptive Use and Fibrocystic Breast Disease With Special Reference to Its Histopathology23. Journal Of The National Cancer Institute 1983, 71: 5-9. PMID: 6575209, DOI: 10.1093/jnci/71.1.5.Peer-Reviewed Original ResearchConceptsOral contraceptive useFibrocystic breast diseaseOral contraceptivesContraceptive useBiopsy specimensBreast diseaseHospital-based case-control studyCase-control studyHigh atypiaEpithelial atypiaGross cystsHistopathologic characteristicsFibrocystic diseaseAtypiaContraceptivesDiseaseMicroscopic cystsCystsNew HavenSimilar patternPapillomatosisHistopathologySpecial referenceCasesControl
1982
A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM
KELSEY J, LIVOLSI V, HOLFORD T, FISCHER D, MOSTOW E, SCHWARTZ P, O'CONNOR T, WHITE C. A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM. American Journal Of Epidemiology 1982, 116: 333-342. PMID: 7114042, DOI: 10.1093/oxfordjournals.aje.a113417.Peer-Reviewed Original ResearchConceptsCase-control studyEndometrial cancerHospital-based case-control studyEstrogen replacement therapyOral contraceptivesDecreased riskReplacement therapyElevated riskOlder ageCancerStatistical significanceWomenRiskNulliparityOverweightMenopauseEndometriumPregnancyContraceptivesTherapyEpidemiology
1981
AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY
HILDRETH N, KELSEY J, LIVOLSI V, FISCHER D, HOLFORD T, MOSTOW E, SCHWARTZ P, WHITE C. AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY. American Journal Of Epidemiology 1981, 114: 398-405. PMID: 7304575, DOI: 10.1093/oxfordjournals.aje.a113207.Peer-Reviewed Original ResearchConceptsEpithelial ovarian cancerOvarian cancerPost-menopausal estrogensAge group 45Case-control studyOveractive thyroidUnderactive thyroidOral contraceptivesGroup 45Risk factorsFamily historyEpidemiologic studiesEpithelial carcinomaPrior useCancerLater ageThyroidWomenRiskMenopauseNumber of yearsEndometriumCarcinomaContraceptivesEstrogen
1979
Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia
Livolsi V, Stadel B, Kelsey J, Holford T. Fibroadenoma in oral contraceptive users. A histopathologic evaluation of epithelial atypia. Cancer 1979, 44: 1778-1781. PMID: 498048, DOI: 10.1002/1097-0142(197911)44:5<1778::aid-cncr2820440535>3.0.co;2-y.Peer-Reviewed Original ResearchConceptsEpithelial atypiaLong-term usersOral contraceptivesOral contraceptive useOral contraceptive usersFibrocystic diseaseHistopathologic evaluationBreast diseaseContraceptive usersCytologic atypiaContraceptive useEpithelial componentAtypiaEpidemiological investigationsFibroadenomaDiseaseContraceptives
1978
Fibrocystic Breast Disease in Oral-Contraceptive Users — A Histopathological Evaluation of Epithelial Atypia
Livolsi V, Stadel B, Kelsey J, Holford T, White C. Fibrocystic Breast Disease in Oral-Contraceptive Users — A Histopathological Evaluation of Epithelial Atypia. New England Journal Of Medicine 1978, 299: 381-385. PMID: 566853, DOI: 10.1056/nejm197808242990803.Peer-Reviewed Original ResearchConceptsFibrocystic breast diseaseOral contraceptivesLong-term usersBreast cancerEpithelial atypiaFibrocystic diseaseBreast diseaseOral contraceptive usersLong-term usePremenopausal womenHistopathological evaluationHistologic standpointCystic diseasePremalignant formsEpidemiological studiesDiseaseContraceptivesAtypiaCancerWomenSignificant differencesNontakersIncidenceORAL CONTRACEPTIVES AND BREAST DISEASE
KELSEY J, HOLFORD T, WHITE C, MAYER E, KILTY S, ACHESON R. ORAL CONTRACEPTIVES AND BREAST DISEASE. American Journal Of Epidemiology 1978, 107: 236-244. PMID: 629261, DOI: 10.1093/oxfordjournals.aje.a112530.Peer-Reviewed Original ResearchConceptsBenign breast diseaseOral contraceptivesBreast diseaseSequential oral contraceptivesCombination oral contraceptivesAge group 20Case-control studyCorpus uteriRelative riskBreast cancerGroup 20ContraceptivesNumber of casesAge groupsSignificant associationCancerDiseaseLarge hospitalsWomenRiskHospitalUterusBreastRole of Oral Contraception in Congenital Malformations of Offspring
BRACKEN M, HOLFORD T, WHITE C, KELSEY J. Role of Oral Contraception in Congenital Malformations of Offspring. International Journal Of Epidemiology 1978, 7: 309-317. PMID: 744667, DOI: 10.1093/ije/7.4.309.Peer-Reviewed Original ResearchConceptsOral contraceptivesCongenital malformationsHealthy control infantsOral contraceptive useCase-control studyTime of conceptionOccurrence of malformationsControl infantsMaternal exposureOral contraceptionContraceptive useMalformed infantsSpecific estrogenSpecific diagnosisControl studyPregnancyMalformationsContraceptivesCardiovascular defectsInfantsExposureWomenProgestogensOffspringEstrogen